Skip to main content

Advertisement

Log in

Mixed provision of health care services with double coverage

  • Published:
Journal of Economics Aims and scope Submit manuscript

Abstract

This paper studies the effect of two alternative regulations of a health care market characterized by mixed provision. Health care is considered as a bundle of mild and severe illness treatments. A free national health service (NHS) offering universal coverage and preferred for severe illnesses treatments, but congested for mild ones, competes with a private health service which is not congested and preferred for mild illnesses care. Either an exclusive subscription regulation, where users are forced to demand health care from only one service; or a non-exclusive subscription regulation that allows choosing for each kind of illness a different health service can be implemented. The move from an exclusive to a non-exclusive regulation implies some users shifting to the private provider for mild illnesses only. This leads to an overall reduction of congestion in the NHS that always benefits users and leads to a less costly NHS under some conditions. Under the latter regulation the private service specializes in mild illnesses with higher profits, while all severe cases are treated by the NHS. Finally, social welfare is also higher under the non-exclusive regulation, even assuming a positive social cost of raising funds to cover the public health care, if such inefficiency is moderate or the NHS is less costly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Notes

  1. Spanish NHS included 59.11% of hospitals, 79.31% of beds and 71.46% of the working surgery rooms in 2014. See Estadística Nacional de Hospitales 2014. https://www.msssi.gob.es/estadEstudios/estadisticas/docs/TablasSIAE2014/SIAE_2014_nacionales.pdf

  2. The SISLE-SNS 2015 report on waiting lists in Spain sets an average of 58 days of delay for users expecting for specialized consultation and 69 for minor surgery (e.g. cataracts). See http://www.msssi.gob.es/estadEstudios/estadisticas/inforRecopilaciones/docs/LISTAS_PUBLICACION_DIC15.pdf

  3. The Spanish National Health Survey (ENSE 2011–2012) reports that 12.5% of the population has double coverage and 0.9% has only private health care (a few non-salaried and high income workers not obliged to join the NHS). See http://www.msssi.gob.es/estadEstudios/estadisticas/encuestaNacional/encuestaNac2011/PresentacionENSE2012.pdf

  4. The Spanish NHS delivered 83.35% of the consultations, 71.26% of the surgeries, and 76.18% of the emergencies performed in 2014. Besides, relative endowments on high-technology medical equipment are larger in the NHS: 81.34% of X-ray, 71.83% of Computerized Axial Tomography, 53.38% of Magnetic Resonance Imaging, 85.71% of Radiation Cobalt pumps and 64.91% of Mammographers. (See the link in Footnote 1).

  5. The Barómetro Sanitario 2015 survey made to 7,800 Spanish residents about their preferences of public vs. private health care showed an overall preference for public health care: 68.1 vs. 25.6% in primary care, 61.9 vs. 31.2% in emergencies, 53.8 vs. 37.3% in specialized attention and 62.9 vs. 30% in hospital admissions. The difference up to 100% prefer both. The most important reason to prefer a public hospital was “the up-to-date status and level of high-technology medical equipment” (valued as 7.71 over 10). Regarding waiting time in Emergencies at the public health care system, 63.2% of the respondents reported that they were treated very quickly or quite quickly. See https://www.msssi.gob.es/estadEstudios/estadisticas/docs/BS_2015/PresentacionWebBS_2015.pdf

  6. The assumption that NHS is not congested for severe illnesses, those where life is at risk, is consistent with the usual assignment of priorities in elective surgery waiting lists. The medical assessment on the severity of the illness is considered the most important item, for 84% of respondents in the Spanish Barómetro Sanitario 2015 survey, to assign priority to patients in waiting lists for surgery. Unfortunately, Spanish data on waiting times in surgery do not distinguish by surgical procedure but rather by surgery specialties which include any degree of severity surgery within each specialty. However, available data on elective surgery waiting times for Australian public hospitals for the period July 2015 to June 2016 distinguishes between surgical procedures indicating that Coronary artery bypass graft was the procedure with the shortest median waiting time (13 days) and Septoplasty (to fix a deviated septum) had the longest median waiting time (209 days) followed by Total Knee replacement (188 days) where the average median waiting time in 2015–2016 was 37 days. This shows some anecdotal evidence that when life is at risk surgery is undertaken as soon as possible in public health care services. See http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=60129557693.

  7. According to Barros and Siciliani (2012), the theoretical literature about the public–private interface focuses on either the first margin or the second margin, but hardly ever on both.

  8. As pointed out in Martinez-Giralt (2014), the optimal choice for an individual reflects the balance between (expected) health care demand, the freedom to choose providers and his(her) budget constraint.

  9. A complete review is provided in Barros and Siciliani (2012), including theoretical and empirical issues with interesting examples from different countries.

  10. Dual practice is the non-exclusive allocation of physicians to either the public or the private health care sector (see González (2004), Biglaiser and Ma (2007), González and Macho-Stadler (2013), Eggleston and Bir (2006) or García-Prado and González (2011)).

  11. A rationing policy is also found in Barros and Olivella (2005), addressing patient selection. They focus on patients allowed to be treated in the NHS. Full cream skimming, all the mildest cases for the private sector while the worst cases remain on the waiting list, is not frequently observed.

  12. Barros et al. (2008) and Moreira and Barros (2010) study non-voluntary double coverage in Portugal, some people are covered by a NHS and other health plan due to their profession, as civil servants.

  13. In two-sided markets a platform allows to interact two types of end-users, providers and consumers. In the health market, physicians treat patients through managed care organizations.

  14. Each organization has its network of physicians. In a HMO, a primary care doctor who approves referrals to see network specialists must be chosen. There is no reimbursement in visits of doctors outside the network. It is cheaper for patients since co-payments are lower and there are no deductibles. In a PPO patients go to specialists without a referral and visits outside the network are partially reimbursed (they pay a higher cost percentage than in network visits). It is more expensive since it is more flexible.

  15. Martinez-Giralt (2014) focuses in the preferred provider market where PPOs compete to attract enrollees and providers compete for patients and to be selected by PPOs.

  16. Health service A can be a NHS financed by taxes while health service B a private health care provider. The assumption of a better NHS in severe illness treatments can be difficult to justify in some countries although in others (e.g. Spain) can be taken. Anyway, our model hinges on the case where each particular health care provider is better suited for a different service included in the health care bundle.

  17. A patient with low value of time, for example, a retired person, will be located closer to 0,  thus not worried about waiting in attending health service A. The waste of time of attending health service A is unacceptable for a CEO of an important firm, therefore she is more likely to attend health service B.

  18. As in Barros and Martinez-Giralt (2002): “For small problems people face a trade-off between quality, cost, and horizontal differentiation effects (such as traveling time), for more severe problems the main worry is quality of care”. Barros and Siciliani (2012) state that sometimes, waiting times can be zero or low in the public sector (as in cancer treatment) and the choice is mainly driven by clinical quality.

  19. The case where users can be sorted out in two groups according to their probability of suffering a severe illness is discussed in the robustness section below. The parameter \( \rho \) might be an indicator of the incidence of severe illnesses, which is affected by particular health policies or money spent in health.

  20. The risk of suffering from a severe illness, in which risk groups are sorted out, is not exactly the probability of being treated from a severe illness. However, in our model this difference is not important, since we have assumed that there is no congestion in treatment for severe illness, all patients are treated.

  21. As patients value not only the price of the service but also their time, the social welfare maximizing price needs not be equal to the marginal cost.

  22. Another option is to set zero prices. This is particularly relevant for Spain, because to reduce waiting lists in the NHS, people are diverted to private providers of health care without any charge.

  23. We use an upper bar to identify a variable in the NES regulation.

  24. For instance, when \( k=d=0 \), \(w=0.1\), \( c=1 \), and \(\rho =0.1 \) it is required that \( \delta \ge 1.75\) and for \(\rho =0.5 \) a value \( \delta \ge 2.66\), is necessary to find larger welfare level under the ES regulation. Note that \( \hat{\delta } \) is higher the higher \( k,d,w,\rho \) and the lower c.

  25. An Appendix including the complete derivation of the expressions, equilibria and proofs for item (i) of this section is available from authors upon request.

References

  • Bardey D, Rochet J-C (2010) Competition among health plans: a two-sided market approach. J Econ Manag Strategy 19(2):435–451

    Article  Google Scholar 

  • Barros PP, Martinez-Giralt X (2002) Public and private provision of health care. J Econ Manag Strategy 11(1):109–133

    Article  Google Scholar 

  • Barros PP, Olivella P (2005) Waiting lists and patient selection. J Econ Manag Strategy 14(3):623–646

    Article  Google Scholar 

  • Barros PP, Machado M, Sanz de Galdeano A (2008) Moral hazard and the demand for health services: a matching estimator approach. J Health Econ 27(4):1006–1025

    Article  Google Scholar 

  • Barros PP, Siciliani L (2012) Public and private sector interface. In: Pauly Mark, McGuire Thomas, Barros Pedro P (eds) Handbook of health economics, vol 2. Elsevier, Amsterdam, pp 927–1001

    Google Scholar 

  • Biglaiser G, Albert Ma CT (2007) Moonlighting: public service and private practice. RAND J Econ 38(4):1113–1133

    Article  Google Scholar 

  • Brekke KR, Sorgard L (2007) Public versus private health care in a national health service. Health Econ 16(6):579–601

    Article  Google Scholar 

  • Buitrago G, Bardey D (2015) Voluntary health plan subsidies and public expenditure. Documentos CEDE 2015-34, Universidad de Los Andes—CEDE

  • Eggleston K, Bir A (2006) Physician dual practice. Health Policy 78:157–166

    Article  Google Scholar 

  • García-Prado A, González P (2011) Whom do physicians work for? An analysis of dual practice in the health sector. J Health Polit Policy Law 36(2):265–294

    Article  Google Scholar 

  • González P (2004) Should physicians’ dual practice be limited? An incentive approach. Health Econ 13(6):505–524

    Article  Google Scholar 

  • González P, Macho-Stadler I (2013) A theoretical approach to dual practice regulations in the health sector. J Health Econ 32(1):66–87

    Article  Google Scholar 

  • González-Álvarez ML, Clavero-Barranquero A (2009) Inequalities in health care utilization in Spain due to double insurance coverage: an Oaxaca-Ramson decomposition. Soc Sci Med 69(5):793–801

    Article  Google Scholar 

  • Hoel M, Sæther EM (2003) Public health care with waiting time: the role of supplementary private health care. J Health Econ 22(4):599–616

    Article  Google Scholar 

  • Iversen T (1997) The effect of a private sector on the waiting time in a national health service. J Health Econ 16(4):381–396

    Article  Google Scholar 

  • Jofre-Bonet M (2000) Health care: private and/or public provision. Eur J Polit Econ 16(3):469–489

    Article  Google Scholar 

  • Lungen M, Stollenwerk B, Messner P, Lauterbach KW, Gerber A (2008) Waiting times for elective treatments according to insurance status: a randomized empirical study in Germany. Int J Equity Health 7:1

    Article  Google Scholar 

  • Martinez-Giralt X (2014) Preferred-provider market. In: Culyer A (ed) Encyclopedia of health economics, vol 3. Elsevier, San Diego, pp 103–107

    Chapter  Google Scholar 

  • Moreira S, Barros PP (2010) Double coverage and demand for health care: evidence from quantile regression. Health Econ 19(9):1075–1092

    Article  Google Scholar 

  • Olivella P (2003) Shifting public-health-sector waiting lists to the private sector. Eur J Polit Econ 19(1):103–132

    Article  Google Scholar 

  • Rodríguez M, Stoyanova A (2004) The effect of private insurance access on the choice of GP/specialist and public/private provider in Spain. Health Econ 13(7):689–703

    Article  Google Scholar 

  • Roger G (2016) Two-sided competition with vertical differentiation. J Econ, forthcoming. doi:10.1007/s00712-016-0507-3

Download references

Acknowledgements

We would like to thank the very useful comments and suggestions made by the editor, the referees as well as those by Xavier Martinez-Giralt and Rafael Moner-Colonques. Jose J. Sempere-Monerris gratefully acknowledges financial support from Generalitat Valenciana under the project PROMETEOII/2014/054.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cristina Pardo-Garcia.

Appendix

Appendix

Equilibrium expressions

In this section of the Appendix we will present the equilibrium expressions corresponding to both the ES and the NES regulation for the private and the regulated equilibrium.

ES regulation

Private equilibrium

Equilibrium price,

\(p_{B}^{*}=\frac{1+k+d-\rho (w-c)}{2}.\)

Demands at equilibrium,

\(\alpha _A ^{*}=\frac{3+k+d+\rho (c+w)}{2(2+k)}, (1-\alpha _A ^{*})=\frac{1+k-d-\rho (c+w)}{2(2+k)}. \)

Equilibrium profits,

\(\pi _{A}^{*}=I^{*}-\frac{(d+\rho c)(3+k+d+\rho (c+w))}{2(2+k)}\), and \(I^{*}= \frac{(d+\rho c)(3+k+d+\rho (c+w))}{2(2+k)};\) \(\pi _{B}^{*}=\frac{(1+k-d-\rho (c+w))^2}{4(2+k)}\)

Consumer surplus,

$$\begin{aligned}&cs^{*}=v-\frac{1}{2}+ \rho w_B-p_{B}^{*}(1-\alpha _A ^{*})+(1+\rho w)\alpha _A ^{*}-(1+k) (\alpha _A ^{*})^2\\&=v-\frac{1}{2}{+} \rho w_B\\&\quad {+} \frac{{(1{-}d)^2-k (2{+}k) (5{+}2 k){+}2 d (\rho (c{+}w)\!-\!k (3{+}k)){+}2 \rho ((7{+}k (5{+}k)) w{-}c k (3{+}k)){-}2 c \rho {+}\rho ^2 (c{+}w)^2}}{4 (2{+}k)^2} \end{aligned}$$

Social welfare,

$$\begin{aligned} sw^{*}= & {} v {-}\frac{1}{2}{-}d{+} \rho \left( w_{B}{-}c\right) {+} \left( 1{+}\rho w\right) \alpha _{A}^{*}{-}\left( 1{+}k\right) \left( \alpha _A^{*}\right) ^{2} {-}\left( \delta {-}1\right) \left( d{+}\rho c\right) \alpha _A^{*}\\= & {} v {-}\frac{1}{2}{-}d{+} \rho \left( w_{B}{-}c\right) {+}\frac{\left( 1{+}\rho w{-}\left( \delta {-}1\right) \left( d{+}\rho c\right) \right) \left( 3{+}k{+}d{+} \rho \left( c{+}w\right) \right) }{2 \left( 2{+}k\right) }\nonumber \\&-\,\frac{\left( 1+k\right) \left( 3+k+d+\rho \left( c+w\right) \right) ^2}{4 \left( 2+k\right) ^2} \end{aligned}$$

Regulated equilibrium.

Equilibrium price,

\(p_{B}^{r}=d+ \rho c\).

Demands at equilibrium, \(\alpha _A ^{r}=\frac{1+d+\rho (c+w)}{2+k}\), \((1-\alpha _A ^{r })=\frac{1+k-d-\rho (c+w)}{(2+k)}\).

Equilibrium profits, \(\pi _{A}^{r }=I^r-\frac{(d+c \rho ) (1+d+\rho (c+w))}{2+k}\), and \(I^{r}= \frac{(d+\rho c)(1+d+\rho (c+w))}{2+k}\); \(\pi _{B}^{r }=0\)

Consumer surplus,

$$\begin{aligned} cs^{r}= & {} v{-}\frac{1}{2}{+} \rho w_B{-}p_{B}^{r }(1{-}\alpha _A ^{r }){+}(1{+}\rho w)\alpha _A ^{r }{-}(1{+}k) (\alpha _A ^{r })^2\nonumber \\= & {} v{-}\frac{1}{2}{+} \rho w_B {+}\frac{(1{-}d)^2{+}d (2 \rho (c{+}w){-}k (k{+}4)){+}\rho \left( 2 w {-}c (k (k{+}4){+}2){+}\rho (c{+}w)^2\right) }{(2{+}k)^2} \end{aligned}$$

Social welfare,

$$\begin{aligned} sw^{r }= & {} v {-}\frac{1}{2}{-}d{+} \rho \left( w_{B}{-}c\right) {+} \left( 1{+}\rho w\right) \alpha _{A}^{r }{-}\left( 1{+}k\right) \left( \alpha _A^{r }\right) ^{2} {-}\left( \delta {-}1\right) \left( d{+} \rho c\right) \alpha _A^{r}\\= & {} v {-}\frac{1}{2}{-}d{+} \rho \left( w_{B}{-}c\right) {+}\frac{\left( 1{+}\rho w{-}\left( \delta {-}1\right) \left( d{+}\rho c\right) \right) \left( 1{+}d{+} \rho \left( c{+}w\right) \right) }{\left( 2{+}k\right) }\nonumber \\&-\,\frac{\left( 1+k\right) \left( 1+d+\rho \left( c+w\right) \right) ^2}{\left( 2+k\right) ^2} \end{aligned}$$

NES regulation

Private equilibrium

Equilibrium price,

\({\bar{p}}_{B}^{*}=\frac{1+k+d}{2}\).

Demands at equilibrium,

\(\bar{\alpha _A}^{*}=\frac{3+k+d}{2(2+k)}\), \((1-\bar{\alpha _A}^{*})=\frac{1+k-d}{2(2+k)}\).

Equilibrium profits,

\({\bar{\pi }}_{A}^{*} =\bar{I}^{*}-\frac{d(3+k+d)}{2(2+k)}- \rho c\), and \(\bar{I}^{*}=\frac{d(3+k+d)}{2(2+k)}+\rho c;\) \({\bar{\pi }}_{B}^{*} =\frac{(1+k-d)^2}{4(2+k)}\)

Consumer surplus,

$$\begin{aligned} \bar{cs}^{*}= & {} v-\frac{1}{2}+ \rho w_A-{\bar{p}}_{B}^{*}(1-{\bar{\alpha }}_A ^{*})+{\bar{\alpha }}_A ^{*}-(1+k) ({\bar{\alpha }}_A ^{*})^2\\= & {} v{-}\frac{1}{2}{+} \rho w_A {-}\frac{(1{+}k{-}d) (1{+}k{+}d)}{4 (2{+}k)}{+}\frac{3{+}k{+}d}{2(2{+} k)}{-}\frac{(1{+}k) (3{+}k{+}d)^2}{4 (2{+}k)^2} \end{aligned}$$

Social welfare,

$$\begin{aligned} \bar{sw}^{*}= & {} v -\frac{1}{2}-d+ \rho (w_{A}-c) + {\bar{\alpha }}_{A}^{*}-(1+k) ({\bar{\alpha }}_A^{*})^{2}-(\delta -1)(d{\bar{\alpha }}_A^{*}+\rho c)\\= & {} v -\frac{1}{2}-d+ \rho (w_{A}-\delta c)+\frac{(1-(\delta -1)d)(3+k+d)}{2(2+ k)}\\&-\,\frac{(1+k) (3+k+d)^2}{4 (2+k)^2} \end{aligned}$$

Regulated equilibrium.

Equilibrium price,

\({\bar{p}}_{B}^{r}=d\).

Demands at equilibrium,

\({\bar{\alpha }}_A ^{r}=\frac{1+d}{2+k}\), \((1-{\bar{\alpha }}_A ^{r })=\frac{1+k-d}{(2+k)}\).

Equilibrium profits,

\({\bar{\pi }}_{A}^{r }=I-\frac{d (1+d)}{2+k}- \rho c\), and \(\bar{I}^{r}=\frac{d(1+d)}{(2+k)}+\rho c\); \({\bar{\pi }}_{B}^{r }=0\)

Consumer surplus,

$$\begin{aligned} \bar{cs}^{r }= & {} v-\frac{1}{2}+ \rho w_A-{\bar{p}}_{B}^{r }(1-{\bar{\alpha }}_A ^{r })+{\bar{\alpha }}_A ^{r }-(1+k) ({\bar{\alpha }}_A ^{r })^2\\= & {} v-\frac{1}{2}+ \rho w_A -d+\frac{(1+d)^2}{(2+k)^2} \end{aligned}$$

Social welfare,

$$\begin{aligned} \bar{sw}^{r }= & {} v -\frac{1}{2}-d+ \rho (w_{A}-c) + {\bar{\alpha }}_{A}^{r }-(1+k) ({\bar{\alpha }}_A^{r })^{2}-(\delta -1)(d{\bar{\alpha }}_A^{r}+\rho c)\\= & {} v {-}\frac{1}{2}{+} \rho (w_{A}{-}c){+}\frac{(1{+}d)(1{-}d(1{+}k)){-}(2{+}k)(d(1{+}d){+}(2{+}k)c \rho )(\delta -1)}{(2+k)^2} \end{aligned}$$

Proof of Proposition 1

Throughout the proof, the most restrictive conditions to ensure positive demands at equilibrium are used. Those conditions read \(0<w<\frac{ 1+k-d}{\rho }-c\) and also \(d<1+k\).

  • We first prove that consumer surplus is greater under the NES regulation:

Notice that \(\overline{cs}^{*}>cs^{*}\) iff

\(2 \left( c (1+k (k+3)-d)-w (7+k (5+k)+d)+2 (2+k)^2 w\right) -\rho (c+w)^2>0\)

The latter inequality holds if \(w<\frac{ 2(1+ k (k+3)-d)}{\rho }-c.\) Since \(\frac{ 1+k-d}{\rho }-c<\frac{ 2(1+ k (k+3)-d)}{\rho }-c\) then \(\overline{cs}^{*}>cs^{*}\). That is, since the condition for positive demands is stronger then the result is proven.

  • National Health Service profits relative performance:

We have that \({\bar{\pi }}_{A}^{*}>\pi _{A}^{*}\) iff \(\frac{d(c+w)-c(1+k-d-\rho (c+w))}{2 (2+k)}>0\)That inequality holds if \(d > \hat{d}=\frac{c( 1+k -\rho (c+w))}{ w+2c}\), where \(\hat{d}\) is positive. Therefore, the conclusion is that the NHS is less costly under the NES regulation if the marginal cost of mild illness treatments is large enough.

  • The private Health service is better off under the NES regulation.

By inspection, \({\bar{\pi }}_{B}^{*} =\frac{(1+k-d)^2}{4(2+k)}>\pi _{B}^{*}=\frac{(1+k-d-\rho (c+w))^2}{4(2+k)}\)

  • Social welfare is larger under the NES regulation.

  1. (i)

    For the case of no inefficiency, i.e. for \(\delta =1\), \(\overline{sw}^{*}>sw^{*}\) iff

    \(c^2 (1+k) \rho +2 c \left( 1+(d+3) k+k^2+d\right) +2 w (3+2 k (k+3)-d-c \rho )-(3+k) \rho w^2>0.\)

    The inequality is satisfied for \( w^-<w<w^+ \), where \(w^-\) and \(w^+\) are the lower and upper roots for the expression. It happens that \(w^-<0\) and \(\frac{ 1+k-d}{\rho }-c<w^+\), then \(\overline{sw}^{*}>sw^{*}\) for the conditions that ensure positive demands.

  2. (ii)

    For the inefficiency case, i.e. for \(\delta >1\), \(\overline{sw}^{*}>sw^{*}\) when

\((c+w)(6+(3+k)(4k-2d-\rho (c+w)))+2(2+k)(2c+w)(d-\hat{d})\delta >0\)

But note that the NHS is less costly under the NES if \(d>\hat{d}\) and that \(6+(3+k)(4k-2d-\rho (c+w))\) is always positive using the upper limits of w and d indicated in the text. Therefore, if \(d>\hat{d}\) then \(\overline{sw}^{*}>sw^{*}\) for all \(\delta \ge 1\).

Finally, when if \(d<\hat{d}\), the second term is negative and \(\overline{sw}^{*}>sw^{*}\) when

\(\delta <\hat{\delta } \equiv \frac{(c+w)(6+(3+k)(4k-2d-\rho (c+w)))}{2(2+k)(2c+w)(\hat{d}-d)}\).

Regarding the difference of welfare for the regulated case we have a similar proof as above where now the expression required to be positive is

\((c+w)((1+k)^2 +1-2d-\rho (c+w)))+(2+k)(2c+w)(d-\hat{d})\delta >0\).

Therefore, welfare is larger under the regulated NES if either \( \delta =1\), or for \(d>\hat{d}\) regardless the size of \(\delta \), or for \(d< \hat{d}\) when \(\delta < \hat{\delta ^{r}} \) where \( \hat{\delta ^{r}} \equiv \frac{(c+w)((1+k)^2 +1-2d-\rho (c+w)))}{(2+k)(2c+w)(\hat{d}-d)}\) and \(\hat{\delta ^{r}}<\hat{\delta }\).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pardo-Garcia, C., Sempere-Monerris, J.J. Mixed provision of health care services with double coverage. J Econ 123, 49–70 (2018). https://doi.org/10.1007/s00712-017-0550-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00712-017-0550-8

Keywords

JEL Classification:

Navigation